Table 2 Transcriptional co-activators across the deadliest cancer types

From: Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases

No.

Transcriptional co-activators

Cancer type

Reference No.

1.

ADA3

Breast cancer

371

2.

ARA70

Prostate cancer

396,397

3.

BCL9/BCL9L

Breast cancer, Prostate cancer

354,355,393

4.

BRD4

Ovarian cancer, Head and neck cancer, Leukemia, Colorectal cancer, Gastric cancer, Pancreatic cancer

407,454,463,475,505,528

5.

CBP/p300

Prostate cancer, Ovarian cancer, Lung cancer, Leukemia, Colorectal cancer, Liver cancer, Pancreatic cancer,

386,403,431,459,469,490,521

6.

CITED2

Breast cancer, Prostate cancer, Leukemia

360,391,460

7.

COLCA2

Lung cancer

422,423

8.

CRTC1

Head and neck cancer, Esophageal cancer

448,514

9.

CRTC2

Ovarian cancer, Lung cancer, Head and neck cancer, Esophageal cancer

406,426,447,515

10.

DDX17

Breast cancer

369

11.

DDX27

Colorectal cancer

467

12.

DDX5

Leukemia, Gastric cancer

465,509

13.

EYA2

Breast cancer

373,375

14.

HBx

Liver cancer

492

15.

KMT2A

Cervical cancer, Colorectal cancer

416,472

16.

MRTF

Breast cancer, Lung cancer, Leukemia, Gastric cancer

350,439,457,512

17.

PC4

Prostate cancer, Lung cancer

394,437

18.

PIWIL1

Pancreatic cancer

520

19.

PPM1G

Liver cancer

485

20.

SET7

Breast cancer

364

21.

SETD8

Pancreatic cancer

524

22.

SRC

Breast cancer

358

23.

TRIM24

Breast cancer, Ovarian cancer, Cervical cancer, Head and neck cancer, Gastric cancer,

378,409,417,451,502

24.

TRIM28

Cervical cancer

419

25.

VGLL1

Cervical cancer

413

26.

YAP/TAZ

Breast cancer, Ovarian cancer, Head and neck cancer, Colorectal cancer, Liver cancer, Gastric cancer, Pancreatic cancer,

382,383,400,443,478,486,499,525

27.

ZNF282

Esophageal cancer

517